Parenteral Drugs (India) (NSE:PDPL) Cyclically Adjusted Book per Share: ₹0.00 (As of Mar. 2022)


NSE:PDPL Parenteral Drugs (India) Ltd NSE:PDPL
4 GF Score
Price ₹2.90
View Full Analysis

What is Parenteral Drugs (India) Cyclically Adjusted Book per Share?

Parenteral Drugs (India) NSE:PDPL 4 Cyclically Adjusted Book per Share is ₹0.00 as of Mar. 2022. GuruFocus rates NSE:PDPL with a GF Score™ of 4/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Parenteral Drugs (India)'s adjusted book value per share for the three months ended in Mar. 2022 was ₹-276.372. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹0.00 for the trailing ten years ended in Mar. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-06-29), Parenteral Drugs (India)'s current stock price is ₹2.90. Parenteral Drugs (India)'s Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2022 was ₹0.00. Parenteral Drugs (India)'s Cyclically Adjusted PB Ratio of today is .


Parenteral Drugs (India)  (NSE:PDPL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Parenteral Drugs (India) Cyclically Adjusted Book per Share Related Terms


Parenteral Drugs (India) Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Parenteral Drugs (India)'s Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parenteral Drugs (India) Cyclically Adjusted Book per Share Chart

Parenteral Drugs (India) Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Parenteral Drugs (India) Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:PDPL vs ZTS, CTLT, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Parenteral Drugs (India)'s Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parenteral Drugs (India) Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parenteral Drugs (India)'s Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Parenteral Drugs (India)'s Cyclically Adjusted PB Ratio falls into.


NSE:PDPL
4GF Score
Parenteral Drugs (India) Ltd NSE:PDPL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Parenteral Drugs (India) Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Parenteral Drugs (India)'s adjusted Book Value per Share data for the three months ended in Mar. 2022 was:

Adj_Book= Book Value per Share /CPI of Mar. 2022 (Change)*Current CPI (Mar. 2022)
=-276.372/138.8218*138.8218
=-276.372

Current CPI (Mar. 2022) = 138.8218.

Parenteral Drugs (India) Quarterly Data

Book Value per Share CPI Adj_Book
201206 0.000 79.567 0.000
201209 115.574 82.244 195.080
201212 0.000 83.774 0.000
201303 88.470 85.687 143.331
201306 0.000 88.365 0.000
201309 121.315 91.042 184.982
201312 0.000 91.425 0.000
201403 62.698 91.425 95.202
201406 0.000 94.103 0.000
201409 52.713 96.780 75.612
201412 0.000 96.780 0.000
201503 42.629 97.163 60.906
201506 0.000 99.841 0.000
201509 129.718 101.753 176.974
201512 0.000 102.901 0.000
201603 33.737 102.518 45.684
201606 0.000 105.961 0.000
201609 93.549 105.961 122.560
201612 0.000 105.196 0.000
201703 -5.851 105.196 -7.721
201706 0.000 107.109 0.000
201709 -26.720 109.021 -34.024
201712 0.000 109.404 0.000
201803 -45.760 109.786 -57.862
201806 0.000 111.317 0.000
201809 -53.102 115.142 -64.023
201812 0.000 115.142 0.000
201903 -149.893 118.202 -176.041
201906 0.000 120.880 0.000
201909 -168.681 123.175 -190.108
201912 0.000 126.235 0.000
202003 -188.257 124.705 -209.568
202006 0.000 127.000 0.000
202009 -210.397 130.118 -224.471
202012 0.000 130.889 0.000
202103 -229.030 131.771 -241.286
202106 0.000 134.084 0.000
202109 -251.041 135.847 -256.538
202112 0.000 138.161 0.000
202203 -276.372 138.822 -276.372

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹0.00 mean?
Parenteral Drugs (India) (NSE:PDPL) has a Cyclically Adjusted Book per Share of ₹0.00 as of Mar. 2022. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Parenteral Drugs (India) and its competitors.
Is Parenteral Drugs (India)'s Cyclically Adjusted Book per Share too high?
Parenteral Drugs (India)'s current Cyclically Adjusted Book per Share is ₹0.00. Overall, Parenteral Drugs (India) has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Parenteral Drugs (India)'s Cyclically Adjusted Book per Share compare to ZTS and CTLT?
Parenteral Drugs (India)'s Cyclically Adjusted Book per Share of ₹0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Parenteral Drugs (India) and its competitors. Parenteral Drugs (India)'s current Cyclically Adjusted Book per Share is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Parenteral Drugs (India) stock overvalued right now?
Parenteral Drugs (India) (NSE:PDPL) has a current Cyclically Adjusted Book per Share of ₹0.00. The current Cyclically Adjusted Book per Share is ₹0.00. Parenteral Drugs (India)'s overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Parenteral Drugs (India) (NSE:PDPL), the current Cyclically Adjusted Book per Share is ₹0.00 as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Parenteral Drugs (India) Business Description

Address Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.
4GF Score

Get the complete analysis for NSE:PDPL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2.90
Price